Sunday, June 21, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 808 of 1,261
  1. US 8759296

    Bone morphogenic protein binding peptide

    The Regents of the University of California · Granted Jun 24, 2014 · Expires Jun 19, 2034

    granted
  2. US 8759302

    Methods of treating a subject afflicted with an autoimmune disease using predictive biomarkers of clinical response to glatiramer acetate therapy in multiple sclerosis

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 24, 2014 · Expires Jun 19, 2034

    granted
  3. US 8759318

    Phosphoramidate derivatives of guanosine nucleoside compounds for treatment of viral infections

    University College Cardiff Consultants Limited · Granted Jun 24, 2014 · Expires Jun 19, 2034

    granted
  4. US 8759327

    Plasminogen activator inhibitor-1 inhibitors and methods of use thereof to modulate lipid metabolism

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 24, 2014 · Expires Jun 19, 2034

    granted
  5. US 8759325

    Compositions and methods of treatment for inflammatory diseases

    The Regents of the University of Oklahoma · Granted Jun 24, 2014 · Expires Jun 19, 2034

    granted
  6. US 8759332

    Hepatitis C virus inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Jun 24, 2014 · Expires Jun 19, 2034

    granted
  7. US 8758817

    Dosage form containing (S)-pantoprazole as active ingredient

    TAKEDA GMBH · Granted Jun 24, 2014 · Expires Jun 19, 2034

    granted
  8. US 8759314

    Methods for treating multiple sclerosis using antisense oligonucleotides

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Jun 24, 2014 · Expires Jun 19, 2034

    granted
  9. US 8759301

    Gene fusion targeted therapy

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jun 24, 2014 · Expires Jun 19, 2034

    granted
  10. US 8758813

    Abuse-deterrent drug formulations

    Collegium Pharmaceutical, Inc. · Granted Jun 24, 2014 · Expires Jun 19, 2034

    granted
  11. US 8759006

    PSCA: prostate stem cell antigen and distinguishing androgen receptor negative prostate cancer from benign prostatic hyperplasia

    The Regents of the University of California · Granted Jun 24, 2014 · Expires Jun 19, 2034

    granted
  12. US 8758818

    Oral tablet compositions of dexlansoprazole

    SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI · Granted Jun 24, 2014 · Expires Jun 19, 2034

    granted
  13. US 8759284

    Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

    Rani Therapeutics, LLC · Granted Jun 24, 2014 · Expires Jun 19, 2034

    granted
  14. US 8758796

    Functionalizing implantable devices with a poly (diol citrate) polymer

    Northwestern University · Granted Jun 24, 2014 · Expires Jun 19, 2034

    granted
  15. US 8759353

    Co-crystals and pharmaceutical compositions comprising the same

    Vertex Pharmaceuticals Incorporated · Granted Jun 24, 2014 · Expires Jun 19, 2034

    granted
  16. US 8759335

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Jun 24, 2014 · Expires Jun 19, 2034

    granted
  17. US 8759492

    Engineered red-shifted channelrhodopsin variants

    The Regents of the University of California · Granted Jun 24, 2014 · Expires Jun 19, 2034

    granted
  18. US 8759389

    Thiophene-carboxamides useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Jun 24, 2014 · Expires Jun 19, 2034

    granted
  19. US 8758311

    Transdermal patch with extensor means

    Nemaura Pharma Limited · Granted Jun 24, 2014 · Expires Jun 19, 2034

    granted
  20. US 8758778

    Polymeric nano-carriers with a linear dual response mechanism and uses thereof

    The Regents of the University of California · Granted Jun 24, 2014 · Expires Jun 19, 2034

    granted
  21. US 8754051

    Peptide modulators of the δPKC interaction with the d subunit of F1Fo ATP synthase/ATPase and uses thereof

    Georgia Regents Research Institute, Inc. · Granted Jun 17, 2014 · Expires Jun 12, 2034

    granted
  22. US 8754218

    Salts of 6-heterocycle substituted hexahydrophenanthridine derivatives

    TAKEDA GMBH · Granted Jun 17, 2014 · Expires Jun 12, 2034

    granted
  23. US 8754224

    Solid forms of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

    Vertex Pharmaceuticals Incorporated · Granted Jun 17, 2014 · Expires Jun 12, 2034

    granted
  24. US 8754233

    Pyrazolylbenzothiazole derivatives and their use as therapeutic agents

    Dermira (Canada), Inc. · Granted Jun 17, 2014 · Expires Jun 12, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.